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The Working Group on research in adult congenital heart disease (ACHD) was convened in
September 2004 under the sponsorship of National Heart, Lung, and Blood Institute
(NHLBI) and the Office of Rare Diseases, National Institutes of Health, Department of
Health and Human Services, to make recommendations on research needs. The purpose of
the Working Group was to advise the NHLBI on the current state of the science in ACHD
and barriers to optimal clinical care, and to make specific recommendations for overcoming
those barriers. The members of the Working Group were chosen to provide expert input on
a broad range of research issues from both scientific and lay perspectives. The Working Group
reviewed data on the epidemiology of ACHD, long-term outcomes of complex cardiovascular
malformations, issues in assessing morphology and function with current imaging techniques,
surgical and catheter-based interventions, management of related conditions including pregnancy
and arrhythmias, quality of life, and informatics. After research and training barriers were
discussed, the Working Group recommended outreach and educational programs for adults
with congenital heart disease, a network of specialized adult congenital heart disease regional
centers, technology development to support advances in imaging and modeling of abnormal
structure and function, and a consensus on appropriate training for physicians to provide care
for adults with congenital heart disease. (J Am Coll Cardiol 2006;47:701–7) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.074American College of Cardiology Foundation
f
b
n
W
n
B
T
W
a
t
A
H
F
H
C
§
C
M
C
M
N
Gn September 2004, the National Heart, Lung, and Blood
nstitute (NHLBI) and the Office of Rare Diseases, both
omponents of the National Institutes of Health, Depart-
ent of Health and Human Services, jointly convened a
orking Group on research in adult congenital heart
isease (ACHD). The purpose of the Working Group was
o advise the NHLBI on the current state of the science in
CHD and barriers to optimal clinical care, and to make
pecific recommendations for overcoming those barriers.
he members of the Working Group (listed in the Appen-
ix in the online version of this paper) were chosen to
rovide expert input on a broad range of research issues
From the *Department of Pediatrics, Children’s Hospital Los Angeles, Keck
chool of Medicine, University of Southern California, Los Angeles, California;
Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute,
ational Institutes of Health, Department of Health and Human Services, Bethesda,
aryland; ‡Department of Pediatric Cardiology, Children’s Hospital of New York, New
ork Presbyterian Columbia University, Columbia University College of Physicians and
urgeons, New York, New York; §Ahmanson/University of California at Los Angeles
dult Congenital Heart Disease Center, David Geffen School of Medicine, Univer-
ity of California, Los Angeles, School of Medicine, Los Angeles, California;
Department of Surgery, The Children’s Hospital, Harvard Medical School, Boston,
assachusetts; ¶Division of Pediatric Cardiology, Children’s National Medical
enter, George Washington University, Washington, DC; #Department of Cardi-
logy, Brigham and Women’s Hospital and The Children’s Hospital, Harvard
edical School, Boston, Massachusetts; **Division of Epidemiology and Clinical
trom both scientific and lay perspectives. This report com-
ines an overview of research, training, and educational
eeds in the field of ACHD with a discussion of the
orking Group’s recommendations for how to meet those
eeds.
ACKGROUND
o provide the framework for discussion, participants at the
orking Group meeting presented information on various
spects of ACHD. Because issues in the diagnosis and
reatment of ACHD are well-reviewed elsewhere (1–5), this
pplications, National Heart, Lung, and Blood Institute, National Institutes of
ealth, Department of Health and Human Services, Bethesda, Maryland; ††Brown
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hildren’s Memorial Hospital, Northwestern University Feinberg School of
edicine, Chicago, Illinois. The National Heart, Lung, and Blood Institute and the
ational Institutes of Health Office of Rare Diseases financially supported the Working
roup meeting held in Bethesda in September 2004 that stimulated the preparation ofhis paper.
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esearch need.
Congenital heart defects are the most common group of
irth defects, occurring in approximately 8 in 1,000 new-
orns (6). The improvements in diagnostic, interventional,
nd critical care skills have resulted in survival of approxi-
ately 90% of these children to adulthood (7). In 2000, it
as estimated that there were 368,800 adults with simple
ongenital heart disease, 302,500 adults with conditions of
oderate complexity, and 117,000 with conditions of great
omplexity, with a total of 787,800 (8). For the same year,
t is estimated that there are 320,000 children with simple
onditions, 165,000 with moderately complex conditions,
nd 138,000 with highly complex conditions, with a total of
23,000 (9).
Now, for the first time in history, these estimates suggest
hat more adults than children are living with congenital
eart disease, and this population is estimated to be growing
t 5% per year (10). This growth rate predicts that the total
CHD population in 2005 is likely to have reached one
illion. It is possible that this figure is low because of the
any ACHD patients who are not routinely followed up, a
henomenon likely to underestimate in particular the num-
er of minority patients. Furthermore, whereas in the past it
as thought that congenital heart defects seen in adults
epresented the mild and simple portion of the spectrum, it
ow seems that the number of adults with conditions of
oderate or severe complexity outweighs that of children.
his puts a very different face on the requirements for
esearch and education needed to maintain optimal health
nd prevent secondary disability in this population.
As the past has shown, continuing medical breakthroughs
ill result in new populations of adult survivors with ever
ore complex disease. The recipients of the first Norwood
rocedures (11) and the earliest survivors of arterial switch
rocedures (12) are now young adults, and their numbers
ill increase dramatically over the next 10 years. For the first
ime, adults with single-ventricle physiology represent a signif-
cant number of those living with congenital heart defects.
Many of these individuals may not realize that they
hould be receiving regular care, and even for those who
eek care, access may be limited by insurance considerations
nd by the absence of an adequate cadre of pediatric and
dult cardiologists appropriately cross-trained. The limited
ata available suggest that only a fraction of adult patients
ith congenital heart disease are followed up by appropri-
tely trained physicians in a setting in which required
Abbreviations and Acronyms
ACHD  adult congenital heart disease
CHD  congenital heart disease
NHLBI  National Heart, Lung, and Blood Institute
RV  right ventricle/ventricularervices are available. Furthermore, there is no universal data sollection program linking the ACHD centers; hence, the
pportunity to improve patient outcomes has not been
ealized. Because the prevention of secondary disability is an
mportant part of ACHD management, this lost opportu-
ity translates into increased human suffering, reduced
roductivity, and societal cost.
EY SCIENTIFIC QUESTIONS
he Working Group started with the premise that a
ystematic approach to the understanding and management
f ACHD would best meet the needs of patients. Compo-
ents of such an approach include identifying and educating
atients, providing diagnostic and treatment services, iden-
ifying risk factors for adverse outcomes, and expanding the
ool of appropriately trained individuals to care for patients
ith ACHD.
atient identification and education. A large number of
atients with ACHD have no regular cardiology care or are
ot aware that they could benefit from ongoing care. Only
7% to 47% of patients in the Canadian Adult Congenital
eart Center Consortium have had a successful transition
rom pediatric cardiology care to adult medicine, and this is
highly structured health system without significant finan-
ial access issues (13). Twenty-seven percent of these
atients had not had a single evaluation beyond their 18th
irthday. In the Natural History Study, 40% of patients
ith aortic stenosis, pulmonary stenosis, and ventricular
eptal defect had not had a cardiac examination in more
han 10 years (14). In a general population of patients who
ave not been evaluated and followed up as rigorously as in
he Natural History study, this rate is likely to be even
igher.
ssessment tools and management issues. Complete as-
essment of functional status as well as evaluation of
bnormal hemodynamic workload in ACHD requires struc-
ural and functional imaging data coupled with hemody-
amic data. Modeling tools that incorporate anatomic and
uid dynamic information are needed to evaluate complex
ardiac anatomy and support patient specific surgical plan-
ing. Evaluation of functional status in congenital cardiac
alformations requires a multi-modality approach that
ncludes two- and three-dimensional echocardiography, an-
iography and catheter-based hemodynamic evaluations,
omputed tomography, and magnetic resonance imaging, as
ell as the trained technologists and physicians to interpret
he tests.
Assessment of the right ventricle (RV), which plays an
mportant role in many types of ACHD, poses particular
roblems. Many adults with congenital heart disease (CHD)
ave abnormal RVs because the procedures that had early
uccess, with the most rapid improvement in survival were
ither operations on patients with two ventricles in which
he RV was abnormal (e.g., tetralogy of Fallot) or in conditions
n which the RV was the systemic ventricle (e.g., transpo-
ition of the great vessels). Current techniques for assessing
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matical models, which have advanced to include measure-
ent of diastolic as well as systolic function. For the RV,
here is still a lack of adequate geometric models in healthy
earts and disease states. The wide variability in geometry
nd loading conditions of the RV in ACHD makes geo-
etric modeling particularly challenging. Also, limited
nowledge of muscle fiber orientation, and heterogeneity of
aterial properties in the postoperative RV in patients with
CHD, have limited the ability to develop realistic models.
evertheless, such a modeling approach is indispensable for
uantitative assessment of RV performance.
Assessment of cardiovascular status in ACHD also re-
uires consideration of ventricular-vascular coupling. The
entricular-arterial system is designed to receive and deliver
ow through a balance of forces that preserves energy and
inimizes stress relationships between ventricular myocar-
ium, central and peripheral conduits, resistance vessels, and
he microvasculature (15–17). Adult patients with CHDs
ave abnormalities that directly affect key determinants of
entricular-vascular coupling. Specific examples include
onpulsatile systemic venous inflow in single-ventricle pal-
iations (18), impaired atrial-ventricular transport in pa-
ients with atrial-level repair for transposition of the great
rteries (19), pulmonary endothelial dysfunction seen in
ulmonary arterial hypertension and in nonpulsatile sys-
emic venous-pulmonary connections (20), postoperative
iastolic dysfunction (21,22), RV outflow aneurysm in
atients with tetralogy of Fallot (23), and pulmonary arterial
nd aortic root enlargement (24).
Changes in intrinsic heart rate, stroke volume, pulse pres-
ure, systemic arterial impedance, neurohormonal or cardiac
utonomic nervous system activity, or salt and water control
een in such patients may have substantive effects on health
nd functional capacity for affected individuals (25–28).
Numerous challenges face the cardiology practitioner
hen confronted with ACHD patients (29,30). Many patients
ave sequelae that increase in frequency over time, such as
ysrhythmias, sudden death, ventricular and valvular dys-
unction, thrombosis, pulmonary hypertension, and endo-
arditis. Durability of prosthetic materials or pacing therapy
s also of concern (31). Syndromes such as Down syndrome
re associated with progressive medical problems (32), and
uperimposition of adult diseases such as systemic hyper-
ension or atherosclerotic vascular disease further modifies
he underlying congenital cardiovascular defects. Non-cardiac
vents, such as pregnancy or surgery on other body systems,
equire special attention and management.
The management of CHD has evolved through trial and
rror over the past 60 years. Very different strategies have
een used in centers around the world because of a combi-
ation of factors, including wide variations in anatomy, the
nterposition of co-morbidities, the variability in diagnostic
odalities, the serendipity of surgical experience, and the
vailability of support services. As a result, the number of
atients in each subgroup is small in the experience of a gingle institution. Thus, the remarkable advances in man-
gement of CHD have been created through a combination
f the occasional radically new management paradigm
roposed by individuals or institutions and logical incre-
entalism, rather than by carefully designed studies. This
eterogeneity of management has created a diverse set of
ssues, even for patients with the same underlying lesion.
Dysrhythmias affect up to 50% of patients with ACHD
nd include sudden death, ventricular tachycardia, intra-
trial muscle reentry tachycardia/atrial flutter, and bradycar-
ia (33–41). Cardiac pacing is not uncommon in this
etting and may include antitachycardia pacing or single- or
ual-chamber pacing for rate control. The study of electro-
echanical coupling requires sophisticated approaches, in-
luding simultaneous three-dimensional imaging and map-
ing. Cardiac pacing and resynchronization offer many
aluable new approaches to the management of dyssyn-
hrony and arrhythmia but as yet have not been thoroughly
xploited in this population. Newer information about
entricular synchronization and cardiomyopathy have al-
ered the strategies for ventricular pacing, although long-
erm studies of cardiac pacing and cardiomyopathy in
CHD are lacking (42,43).
Most women with CHD reach childbearing age and wish
o become pregnant. Congenital heart disease is now the
ost common form of heart disease encountered during
regnancy in the U.S. The management of pregnant women
ith prosthetic heart valves placed to treat CHD is partic-
larly difficult (44,45). Ideal management strategies are
ifficult to delineate because each center has small numbers
f patients and no collaborative multicenter studies have
een performed. Because many adults with CHD can now
onceive and bear children, and their children are several-
old more likely to have CHD than the general population,
his group should undergo genetic evaluation to help predict
ecurrence risk. Specific genetic mutations may affect the
isk and specificity of recurrence, so knowledge of the
utations could help in family counseling.
dentification of risk factors for adverse outcomes. Knowledge
f long-term outcomes for adults with complex CHD is
ecessary to provide optimal care and to guide the refine-
ent of intervention in childhood. The importance of
enetics in many facets of medicine has become paramount,
nd new discoveries in cardiology show the genetic contri-
ution to CHD. Specific genetic malformations may affect
utcome, for example, the finding that mutations in the
ranscription factor NkX2.5 not only are associated with
tructural cardiac malformations, but also may predispose
ndividuals to arrhythmias (46,47). It is reasonable to
peculate that individuals with ACHD and this mutation
ay experience more morbidity than unaffected individuals.
Three congenital malformations commonly encountered
n adulthood are tetralogy of Fallot, transposition of the
reat arteries, and single-ventricle physiology.
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NHLBI Adult Congenital Heart Disease Report February 21, 2006:701–7ETRALOGY OF FALLOT. Tetralogy of Fallot is the most
ommon complex defect with the longest surgical history
nd the greatest documentation of outcomes. Long-term
ostoperative residua include RV outflow tract obstruction
r aneurysm, pulmonary regurgitation, distal pulmonary
rtery obstruction, atrial and ventricular incisional scars,
esidual or recurrent ventricular septal defects, myocardial
ypertrophy, chamber enlargement, RV and left ventricular
ysfunction, aortic root dilation, and aortic regurgitation
48–51). The three most common late causes of death are
rrhythmia, heart failure, and complications of reoperation
52). Pulmonary regurgitation, far from being benign as
nitially thought, has emerged as a principal reason for late
eoperation. There is no consensus on the optimal timing of
ulmonary valve replacement. In addition, the RV outflow
ract reconstruction may affect cardiac autonomic nervous
ctivity, which may in turn affect exercise hemodynamics via
eart rate recovery, respiratory physiology, and a decreased
ystolic blood pressure response with reduced cardiac output
eserve (53).
Long-term survival after complete intracardiac repair is
6% at 32 years (52). However, the risk of sudden cardiac
eath increases in a time-dependent fashion, and by 30 years
fter surgery, is approximately 6% to 9% (54). The etiology
f sudden death is multifactorial; identified risk factors
nclude QRS duration 180 ms, older age at repair, sig-
ificant pulmonary valve regurgitation (55), with potential
or prognostic categorization via electrophysiologic testing.
s noted earlier, these factors may change as patients from
ater surgical eras reach adulthood. Furthermore, there is
ncreasing evidence that chronic pulmonary regurgitation
eads to progressive RV diltation and dysfunction, requiring
ntervention to recover performance. Management of this
atient group remains controversial with respect to timing
f intervention and whether associated procedures impact
n long-term outcomes (56).
OMPLETE OR D-TRANSPOSITION OF THE GREAT ARTERIES.
omplete or d-transposition of the great arteries was uniformly
ethal until the advent of the atrial switch procedures
Mustard, Senning). However, these procedures opened up
Pandora’s box of long-term problems, including failure of
he systemic RV, baffle leaks and obstruction, pulmonary
ypertension, and dysrhythmias (48).
For the past two decades, the arterial switch operation
ASO) has been the treatment of choice for patients with
ransposition of the great arteries; midterm follow-up has
onfirmed good systemic ventricular function and lack of
rrhythmias. This can be contrasted with the known long-
erm increased mortality and morbidity with atrial switch
rocedures. However, long-term concerns after the arterial
witch operation include coronary insufficiency, myocardial
schemia, ventricular dysfunction and arrhythmias, and
ssues regarding stenoses at the great arterial anastomotic
ites as well as development of aortic and pulmonary dilation
nd regurgitation (57). In the series reported by Formigari mt al. (58), 35% had neo-aortic regurgitation (native pulmo-
ary valve), particularly after two to four years postopera-
ively, although most cases were mild and patients remained
table without progression over the follow-up period (me-
ian) of 8.2 years. Losay et al. (57) reported on 1,200
atients with ASO for transposition of the great arteries
etween 1982 and 1999 with prospective follow-up of 1,095
urvivors. Freedom from reoperation was 82% at 15 years,
ith the most frequent cause being pulmonary stenosis,
rimarily at the anastomotic site, and was most frequent
ithin the first nine postoperative years. Moderate or
reater pulmonary stenosis was observed in 3.9%, including
hose who had surgical repair or balloon diltation. Aortic
egurgitation of all grades was seen in 15.5%; aortic regur-
itation of grade II or higher was observed in 3.8% with an
ncrease in frequency over time. Survival was 88% at 10 and
5 years; hazard function for death declined rapidly, with no
eaths after 5 years. Late mortality was related to reinter-
ention or major events in the intensive care units. Good left
entricular function in sinus rhythm was generally
aintained.
INGLE-VENTRICLE PHYSIOLOGY. Single-ventricle physiol-
gy comprises several types of cardiovascular malformation,
uch as hypoplasia of the left or right ventricle, atresia of one
f the atrioventricular valves, double-inlet ventricles, or
ndifferentiated single ventricles. Although collectively sin-
le ventricle is a rare defect, present only in 1.5% of patients
ith CHD (59), it accounts for a disproportionate share of
orbidity and mortality in ACHD. The usual surgical
pproach for single-ventricle physiology culminates in the
ontan procedure, which separates the systemic and pulmo-
ary circulations. Cyanosis is thus eliminated, but the
ystemic circulation often is supported by the single RV,
hich is ill-designed for this purpose as indicated by the
nown late failures of the systemic RV. Reported outcomes
epend on the age of the patient at operation, the precise
natomy, and any previous palliative procedures, as well as
he era of operation and the current modifications relative to
he experience and techniques of the specific institution.
ssues that compromise quality of life include protein-losing
nteropathy, thromboembolic complications, ventricular
ysfunction, and dysrhythmias both early and late after the
ontan procedure (60–62). Cardiorespiratory and ventila-
ory responses to exercise after the Fontan procedure are
ubnormal, including lower-than-expected VO2max, cardiac
utput, and heart rate responses, as well as an abnormal
eduction of normal resting arterial O2 saturation at peak
xercise (63). Pre-adolescents who undergo volume-
nloading surgery at an early age have better aerobic
apacity than those whose surgery is at a later age (64). This
s partially because of the morphology of the systemic
entricle, duration of volume loading and cyanosis, and
egree of atrioventricular valve regurgitation before the
ontan procedure. Diastolic filling abnormalities are com-
on regardless of ventricular morphology. They may exist
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65). Even in long-term Fontan procedure survivors, there is
ften reduced systolic ventricular function despite normal
entricular mass and volume. This may be caused by the
bsence of the normal interaction between two ventricles,
ediated by the interventricular septum, resulting in
arked differences in myocardial twist and strain (66).
raining. The 32nd Bethesda Conference entitled “Care
f the Adult With Congenital Heart Disease” addressed the
ssue of workforce description and educational requirements
or the care of adults with CHD. The Task Force empha-
ized the shortage of trained adult cardiologists and the
ifficult transition from the pediatric cardiologist to a
edical cardiologist for the care of patients with complex
HD. The Bethesda Conference report outlined three
evels of training from basic exposure to CHD patients to
igher levels of specialization. The requirements for ACHD
roviders were outlined in detail, and the report indicated
hat the time required for the training of future ACHD
ardiologists should be determined by a Special Task Force
f the American Board of Internal Medicine and the
merican Board of Pediatrics.
There are many parallels with the status of training of
pecialists for ACHD with that of pediatric cardiology in
he 1960s. During that era, there were never more than one
r two pediatric cardiologists in any large center, and the
ast majority of major hospitals in the United States did not
ave specialists in this area. The advent of clinical training
rants resulted in the training of sufficient personnel to
ring to the bedside the tremendous progress that was being
ade in the diagnosis and treatment of pediatric heart
isease. Not only was there an immediate effect, but this
overnmental effort propagated further advances in clinical
are and research that provided direct and indirect funding
or a critical mass of specialists. The circumstances are
imilar today for ACHD. Rarely does a major medical
enter have more than one or two individuals devoted to this
pecialty, and most general cardiologists do not have specific
xpertise. In many ways, that crisis in ACHD is even greater
han for pediatric cardiology in the 1960s in that there are
ore patients who require care, and they will require care
or a much longer period of time. The superimposition of
cquired heart disease during middle and older adult life
urther complicates their management.
Fortunately, the number and types of training and re-
earch grants have grown since the 1960s. ACHD centers
re eligible to apply for institutional training grants (T32s),
nd a full panoply of individual fellowships, career develop-
ent awards, and research grants is available for profession-
ls interested in ACHD, just as for other areas of interest.
ECOMMENDATIONS
he specific recommendations developed by the NHLBI
orking Group are summarized below, and are meant toomplement recommendations made by the ACC Bethesda tonference 32 and other groups working on these impor-
ant issues:
Outreach programs should be established to identify the
“lost” population of adults with CHD. This effort should
be conducted in conjunction with medical centers,
schools of public health, government offices, and patient
groups.
A network of specialized ACHD regional centers should
be formed. The purposes of this network would be to:
 develop a database that would be used to track
outcomes, formulate best practices, and foster contin-
uous quality improvement based on these best practices.
 develop a rich environment suitable for training and
continuing education of cardiologists in ACHD as
clinicians, researchers, and educators.
 design and conduct multi-center clinical research on
the pressing clinical issues in ACHD. These include
but are not limited to natural history of specific
conditions, interaction of ACHD with adult cardio-
vascular risk factors, assessment and treatment of
ventricular dysfunction, understanding of ventricular-
vascular interactions and their role in circulatory
failure, predictors of risk for sudden death and serious
arrhythmias, understanding of genetic factors influ-
encing outcome, and improved pregnancy management.
Technology should be developed to support hemody-
namic and functional modeling of individual patients, to
improve understanding of cardiac status, and to plan for
future therapy. This will require:
 improvements in imaging systems, image processing
and image display;
 development of near-real-time mechanical models for
surgical planning; and
 engineering solutions to support these activities.
A consensus on training is required, and the NHLBI
Working Group strongly endorses the recommendations
of the 32nd Bethesda Conference on training. New
approaches to training ACHD specialists require:
 cooperative efforts by the American Board of Internal
Medicine, the American Board of Pediatrics, the
NHLBI, and others to facilitate the entry of physi-
cians with medical or medical/pediatric training into
the field of ACHD.
 funding for both clinical and research training to
produce adequate numbers of physicians to provide
care for this large cohort of patients.
 current training programs working with NHLBI to
determine appropriate mechanisms to support train-
ing of ACHD specialists.
UMMARY
ongenital heart disease is arguably one of the most
omplex and variable disease states. Management of CHD
n the pediatric population has only recently been subjected
o systematic study with the establishment of the NHLBI-
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NHLBI Adult Congenital Heart Disease Report February 21, 2006:701–7unded Pediatric Heart Network. Systematic study has been
ffective in reducing mortality and morbidity in other
onditions such as heart failure, cystic fibrosis, and pediatric
ancers. We propose a similar collaborative, multi-disciplinary
pproach for the adult patient with CHD. The heterogene-
ty of these lesions, although adding to the difficulty of
tudy, provides important models for the understanding of
asic embryology, genetics, and physiology with clear ex-
rapolations to acquired cardiac and noncardiac pathology.
herefore, in addition to enhancing the quality of life and
unctionality of this patient group, there will be benefits for
he whole of society.
eprint requests and correspondence: Dr. Gail D. Pearson,
HLBI, 6701 Rockledge Drive, Room 9202, Bethesda, Mary-
and 20892. E-mail: pearsong@mail.nih.gov.
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